By Professor David Goldstein

Journal articles

Mcnamara MG; Bridgewater J; Goyal L; Jacobs T; Wagner AD; Goldstein D; Shroff R; Moehler M; Lowery M; Bekaii-Saab T; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox J; Valle J, 2022, 'What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-064954

Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P, 2022, 'Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study', Supportive Care in Cancer, 30, pp. 8201 - 8210, http://dx.doi.org/10.1007/s00520-022-07272-3

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, 30, pp. 5965 - 5974, http://dx.doi.org/10.1007/s00520-022-07024-3

Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM, 2022, 'Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients', Patient Education and Counseling, 105, pp. 2206 - 2216, http://dx.doi.org/10.1016/j.pec.2022.01.011

Krasovitsky MS; Goldstein D, 2022, 'Destructive soft tissue metastases in advanced colorectal cancer: a case report', Annals of Palliative Medicine, 11, pp. 2170 - 2174, http://dx.doi.org/10.21037/apm-21-362

Maharaj AD; Evans SM; Ioannou LJ; Croagh D; Earnest A; Holland JF; Pilgrim CHC; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Burmeister EA; Evans PM; Hayes TM; Houli N; Knowles B; Leong T; Nikfarjam M; Philip J; Quinn M; Shapiro J; Smith MD; Spillane JB; Wong R; Zalcberg JR, 2022, 'The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer', HPB, 24, pp. 950 - 962, http://dx.doi.org/10.1016/j.hpb.2021.11.005

Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y

Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C, 2022, 'Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: A scoping review', Personalized Medicine, 19, pp. 139 - 153, http://dx.doi.org/10.2217/pme-2021-0096

Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC; Young M-A, 2022, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics, Part A, 188, pp. 725 - 734, http://dx.doi.org/10.1002/ajmg.a.62563

Foo T; Goldstein D; Segelov E; Shapiro J; Pavlakis N; Desai J; Yip D; Zalcberg J; Price TJ; Nagrial A; Chantrill L; Burge M; Karapetis CS; Tebbutt N; Roy AC, 2022, 'The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours', Targeted Oncology, 17, pp. 95 - 110, http://dx.doi.org/10.1007/s11523-022-00869-y

Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2022, 'Corrigendum to “Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy” [Gait Posture 89 (2021) 178–185](S0966636221002514)(10.1016/j.gaitpost.2021.07.010)', Gait and Posture, 92, pp. 1, http://dx.doi.org/10.1016/j.gaitpost.2021.11.006

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2022, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, 105, pp. 452 - 459, http://dx.doi.org/10.1016/j.pec.2021.05.018

Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2022, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, 31, pp. 96 - 108, http://dx.doi.org/10.1002/jgc4.1455

Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G, 2022, 'Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice', Pain, 163, pp. 110 - 124, http://dx.doi.org/10.1097/j.pain.0000000000002384

Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2022, 'Psychological Outcomes in Advanced Cancer Patients After Receiving Genomic Tumor Profiling Results', Health Psychology, 41, pp. 396 - 408, http://dx.doi.org/10.1037/hea0001181

Chiang JCB; Krishnan AV; Goldstein D; Markoulli M, 2022, 'The Impact of Post-Tear Collection Storage on Tear Film Substance P Concentration', Current Eye Research, 47, pp. 1116 - 1120, http://dx.doi.org/10.1080/02713683.2022.2067565

Nguyen M; Segelov E; Goldstein D; Pavlakis N; Shapiro J; Price TJ; Nagrial A; Chantrill L; Leong T; Chen J; Burge M; Karapetis CS; Chau I; Lordick F; Renouf D; Tebbutt N; Roy AC, 2022, 'Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, 22, pp. 39 - 51, http://dx.doi.org/10.1080/14737140.2022.2002689

Perez-Concha O; Goldstein D; Harris MF; Laaksonen MA; Hanly M; Suchy S; Vajdic CM, 2022, 'Uptake of Team Care Arrangements for adults newly diagnosed with cancer', Australian Journal of Primary Health, 29, pp. 20 - 29, http://dx.doi.org/10.1071/py22078

Lundy J; Harris M; Zalcberg J; Zimet A; Goldstein D; Gebski V; Borsaru A; Desmond C; Swan M; Jenkins BJ; Croagh D, 2021, 'EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy', Frontiers in Oncology, 11, pp. 770022, http://dx.doi.org/10.3389/fonc.2021.770022

Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer', Scientific Reports, 11, pp. 1786, http://dx.doi.org/10.1038/s41598-021-81398-y

Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D, 2021, 'AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08666-y

Chiang JCB; Goldstein D; Tavakoli A; Trinh T; Klisser J; Lewis CR; Friedlander M; Naduvilath TJ; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel', Scientific Reports, 11, pp. 22884, http://dx.doi.org/10.1038/s41598-021-02439-0

Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0

Yu A; Street D; Viney R; Goodall S; Pearce A; Haywood P; Haas M; Battaglini E; Goldstein D; Timmins H; Park SB, 2021, 'Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences', Supportive Care in Cancer, 29, pp. 6379 - 6387, http://dx.doi.org/10.1007/s00520-021-06196-8

Aughton K; Elander NO; Evans A; Jackson R; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; Carter R; Cunningham D; Tebbutt NC; Goldstein D; Shannon J; Glimelius B; Hackert T; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Palmer DH; Büchler MW; Ghaneh P; Neoptolemos JP; Greenhalf W, 2021, 'HENT1 predicts benefit from gemcitabine in pancreatic cancer but only with low CDA mRNA', Cancers, 13, pp. 5758, http://dx.doi.org/10.3390/cancers13225758

Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho-Oncology, 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764

Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M, 2021, 'The experiences and needs of australian medical oncologists in integrating comprehensive genomic profiling into clinical care: A nation-wide survey', Oncotarget, 12, pp. 2169 - 2176, http://dx.doi.org/10.18632/ONCOTARGET.28076

Maharaj AD; Evans SM; Zalcberg JR; Ioannou LJ; Graco M; Croagh D; Pilgrim CHC; Dodson T; Goldstein D; Philip J; Kench JG; Merrett ND; Neale RE; White K; Evans P; Leong T, 2021, 'Barriers and enablers to the implementation of multidisciplinary team meetings: A qualitative study using the theoretical domains framework', BMJ Quality and Safety, 30, pp. 792 - 803, http://dx.doi.org/10.1136/bmjqs-2020-011793

Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6

Clifford BK; Jones MD; Simar D; Barry BK; Goldstein D, 2021, 'The effect of exercise intensity on exercise-induced hypoalgesia in cancer survivors: A randomized crossover trial', Physiological Reports, 9, pp. e15047, http://dx.doi.org/10.14814/phy2.15047

Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2021, 'Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy', Gait and Posture, 89, pp. 178 - 185, http://dx.doi.org/10.1016/j.gaitpost.2021.07.010

Lees JG; Abdulla M; Barkl-Luke ME; Livni L; Keating BA; Hayes J; Fiore NT; Park SB; Moalem-Taylor G; Goldstein D, 2021, 'Effect of exercise on neuromuscular toxicity in oxaliplatin-treated mice', Muscle and Nerve, 64, pp. 225 - 234, http://dx.doi.org/10.1002/mus.27329

Giraud P; Racadot S; Vernerey D; Goldstein D; Glimelius B; Van Houtte P; Gubanski M; Spry N; Van Laethem JL; Hammel P; Huguet F, 2021, 'Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, 110, pp. 993 - 1002, http://dx.doi.org/10.1016/j.ijrobp.2021.01.055

Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; van Houtte P; Bonnetain F; Louvet C; Hammel P; Huguet F, 2021, 'Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, 110, pp. 1022 - 1031, http://dx.doi.org/10.1016/j.ijrobp.2021.01.052

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, 81, pp. 3461 - 3479, http://dx.doi.org/10.1158/0008-5472.CAN-20-2496

Battaglini E; Goldstein D; Grimison P; McCullough S; Mendoza-Jones P; Park SB, 2021, 'Chemotherapy-induced peripheral neurotoxicity in cancer survivors: Predictors of long-term patient outcomes', JNCCN Journal of the National Comprehensive Cancer Network, 19, pp. 821 - 828, http://dx.doi.org/10.6004/jnccn.2021.7026

Chiang JCB; Goldstein D; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal nerve changes following treatment with neurotoxic anticancer drugs', Ocular Surface, 21, pp. 221 - 237, http://dx.doi.org/10.1016/j.jtos.2021.06.007

Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, 31, http://dx.doi.org/10.17061/PHRP31122108

Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker T; Corley S; Wilkins MR; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Hgf/c-met inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer', Cancers, 13, pp. 2763, http://dx.doi.org/10.3390/cancers13112763

Oar A; Kneebone A; Lee M; Goldstein D; Sjoquist KM; Le H; Chu J; Barbour A; Gholamrezaei L; Lynam JF; Bece A; Bahamad S; Yip S; Espinoza D; Chantrill LA; Moore A; Lee D; Nguyen QN; Samra J; Mumford J, 2021, 'Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.', JOURNAL OF CLINICAL ONCOLOGY, 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS4172

Kokkinos J; Jensen A; Sharbeen G; McCarroll JA; Goldstein D; Haghighi KS; Phillips PA, 2021, 'Does the microenvironment hold the hidden key for functional precision medicine in pancreatic cancer?', Cancers, 13, http://dx.doi.org/10.3390/cancers13102427

Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I, 2021, 'Family communication about genomic sequencing: A qualitative study with cancer patients and relatives', Patient Education and Counseling, 104, pp. 944 - 952, http://dx.doi.org/10.1016/j.pec.2020.10.022

Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697

Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY, 2021, 'Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)^☆', Annals of Oncology, 32, pp. 533 - 541, http://dx.doi.org/10.1016/j.annonc.2021.01.004

Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D, 2021, 'Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy', JAMA Network Open, 4, pp. E2036695, http://dx.doi.org/10.1001/jamanetworkopen.2020.36695

Trinh T; Park SB; Murray J; Pickering H; Lin CSY; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV, 2021, 'Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial', Supportive Care in Cancer, 29, pp. 1103 - 1110, http://dx.doi.org/10.1007/s00520-020-05591-x

Blinman P; Martin A; Jefford M; Goldstein D; Boadle D; Morris M; Tebbutt N; Aiken C; Harkin A; Segelov E; Haydon A; Iveson T; Stockler MR, 2021, 'Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer', JNCI CANCER SPECTRUM, 5, http://dx.doi.org/10.1093/jncics/pkaa107

McNamara MG; Bridgewater JA; Goyal L; Goldstein D; Shroff RT; Moehler MH; Lowery MA; Bekaii-Saab TS; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox JJ; Valle JW, 2021, 'Gender representation in authorship in later-phase systemic clinical trials in biliary tract cancer (BTC).', Journal of Clinical Oncology, 39, pp. 348 - 348, http://dx.doi.org/10.1200/jco.2021.39.3_suppl.348

Chiang JCB; Goldstein D; Trinh T; Au K; Mizrahi D; Muhlmann M; Crowe P; O’neill S; Edwards K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of sub-basal corneal nerve reduction following neurotoxic chemotherapy', Translational Vision Science and Technology, 10, pp. 1 - 11, http://dx.doi.org/10.1167/tvst.10.1.24

Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2021, 'Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications', Pancreatology, 21, pp. 103 - 114, http://dx.doi.org/10.1016/j.pan.2020.11.022

Back to profile page